EVONETIX develops technology for gene synthesis, aiming to contribute to the biology revolution.

EVONETIX

Princeton Scientific Corp. provides material science and engineering related products, including high-purity single crystals and substrates, as well as particle beam line technology for research and industrial applications.

Princeton Scientific Corp.

We are a Cambridge-based company developing a radically different approach to gene synthesis. Our desktop DNA synthesis platform will provide the ability to synthesise DNA at unprecedented accuracy, scale and speed, accelerating scientists'​ ability to use synthetic biology on a scale not currently possible. 

Innovate UK

Cambridge Consultants

Morningside Group

DCVC

Molten Ventures

Foresite Capital

Providence Investment Company Limited

Page One Ventures

Civilization Ventures

Evonetix Ltd

We're developing a novel silicon array that actively controls #DNAsynthesis, gene assembly and error correction at thousands of discrete sites across its surface. 

Our technology aims to put ultra-parallel #DNA preparation in the hands of researchers, enabling faster turn around and iteration at a scale currently only available in major service centres.

Gene synthesis will turn from a major bottleneck into the opportunity to drive forward the scope and ambition of #syntheticbiology.

Take a look at how it works: https://lnkd.in/gx-qX53v

Engineering biology is already shaping the world for the better, but a transformation in gene synthesis capabilities is needed before it can reach its potential. Our mission is to ignite the #engineeringbiology revolution by putting a gene foundry in every lab.  
 
Find out more below. 
www.evonetix.com

#sytheticbiology #DNA

Next week, our team will be attending the Synthetic and Engineering Biology British-Swiss Summit – a collaborative venture between academics and industry leaders to discuss how we can address healthcare and environmental challenges. 

This year’s summit includes an exciting programme of presentations from the latest advances in cell engineering to scale-up in bioprocessing and AI-driven solutions.

Check out the full agenda here: https://rb.gy/6btcev

#SynBio #EngineeringBiology #GeneSynthesis

Great to meet up with friends and colleagues in the synthetic biology space at this year’s SynBioBeta.
 
Thanks to the BioIndustry Association (BIA) for organising the UK Pavilion, showcasing the great companies shaping synthetic and engineering biology in the UK.
 
Find out more here: https://rb.gy/15dvft
 
#EngineeringBiology #SyntheticBiology #DNA

We’ll be in San Jose for #SynBioBeta2024 next week, joining industry leaders to discuss the transformative nature of synthetic biology and how it can revolutionize healthcare and other industries.
 
With sessions exploring the crucial role of gene synthesis in DNA-driven innovations, from treating disease to addressing some of the challenges presented by the planet, and the importance of biosecurity as the world of synthetic biology is rapidly expanding.
 
See the full agenda here: https://rb.gy/i5kpgr
 
#EngineeringBiology #SyntheticBiology #GeneSynthesis #DNA

We're looking forward to attending SynBioBeta next month as part of BioIndustry Association (BIA)’s UK Pavilion, alongside a network of industry leaders who are committed to using biology to build a better world. 
 
From engineers to investors, innovators, and entrepreneurs, The Global Synthetic Biology Conference gathers a broad range of individuals who share a passion for biological engineering to discuss the industry's latest innovations and cutting-edge technologies and how they are addressing some of the world's greatest challenges.
 
Find out more here: https://rb.gy/hzei35
 
#EngineeringBiology #SyntheticBiology #Sustainability

Metric
Company Name	EVONETIX	Princeton Scientific Corp.
Symbol
MSH ID	COM:EVONETIX	COM:PRINCETONSCIENTIFIC
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Technology
Industry	Biotechnology	Materials Science
Country	GB	US
Stage
Employee Count	41
Website	evonetix.com	princetonscientific.com
LinkedIn	evonetix-ltd	princeton-scientific-corp
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	1.43K
Web Traffic Growth	1.80
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

EVON

COM:EVONETIX

EVONETIX

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue